Department of Periodontology, Center for Dentistry and Oral Medicine (Carolinum), Goethe University Frankfurt/Main, Frankfurt, Germany.
Private Dental Practice, Weilburg, Germany.
J Clin Periodontol. 2024 Sep;51(9):1122-1133. doi: 10.1111/jcpe.14003. Epub 2024 Jun 3.
To retrospectively compare two approaches for the adjunctive use of systemic antibiotics in non-surgical periodontal therapy: one based on the detection of Aggregatibacter actinomycetemcomitans (Aa) and the other on age and severity of periodontitis (Age & PPD). We also assessed the additional benefit of antibiotics in reducing the need for further surgical therapy in each group.
Patients of the Department of Periodontology, Goethe University Frankfurt, Germany, were screened for microbiological testing between 2008 and 2018. Patients were categorized by their microbiological result (Aa+/-) and demographic/clinical data (Age & PPD+/-). Agreement on antibiotic indication was tested. The clinical evaluation focussed on teeth with probing pocket depths (PPDs) ≥ 6 mm.
Analysis of 425 patients revealed 30% categorized as Age & PPD+ and 34% as Aa+. Sixty-three percent had consistent antibiotic recommendations (phi coefficient 0.14, p = .004). Patients in the Age & PPD+ group receiving antibiotics showed the most substantial reduction in the number of teeth with PPD ≥ 6 mm after non-surgical periodontal therapy.
Both strategies resulted in a significant clinical improvement compared with those without antibiotic treatment and restricted antibiotic use similarly, but targeted different patient groups. Younger individuals with severe periodontitis benefited most from antibiotics, reducing the need for additional surgeries. The study was registered in an international trial register (German Clinical Trial Register number DRKS00028768, registration date 27 April 2022, https://drks.de/search/en/trial/DRKS00028768).
回顾性比较两种在非手术牙周治疗中辅助使用全身抗生素的方法:一种基于检测伴放线放线杆菌(Aa),另一种基于年龄和牙周炎严重程度(Age & PPD)。我们还评估了抗生素在减少每组进一步手术治疗需求方面的额外益处。
德国法兰克福歌德大学牙周科的患者于 2008 年至 2018 年期间接受了微生物检测筛查。根据他们的微生物检测结果(Aa+/-)和人口统计学/临床数据(Age & PPD+/-)对患者进行分类。测试了抗生素适应症的一致性。临床评估重点关注探诊袋深度(PPD)≥6mm 的牙齿。
对 425 名患者的分析显示,30%的患者分为 Age & PPD+,34%的患者分为 Aa+。63%的患者有一致的抗生素推荐(phi 系数 0.14,p=0.004)。在接受非手术牙周治疗后,Age & PPD+组接受抗生素治疗的患者 PPD≥6mm 的牙齿数量减少最多。
与未接受抗生素治疗的患者相比,这两种策略均显著改善了临床状况,且抗生素的使用也相似,但针对的是不同的患者群体。患有严重牙周炎的年轻个体从抗生素中获益最大,减少了对额外手术的需求。该研究已在国际临床试验注册中心注册(德国临床试验注册编号 DRKS00028768,注册日期为 2022 年 4 月 27 日,https://drks.de/search/en/trial/DRKS00028768)。